ASCO VALUE FRAMEWORK AND ESMO MAGNITUDE OF CLINICAL BENEFIT SCALE ASSESSMENTS FOR THE IMPLEMENTATION OF NEW TECHNOLOGIES IN HEMATOLOGICAL MALIGNANCIES: CASE STUDY AND CHALLENGES IN THE PRIVATE HEALTHCARE SYSTEM

Introduction: The increasing cost of novel technologies in the oncohematology field, with increasingly flexible regulatory criteria for approval by regulatory agencies, has raised concerns among private Health Technology Assessment (HTA) bodies. The ASCO framework and ESMO-MCBS-H are validated tools...

Descripció completa

Dades bibliogràfiques

Autors principals:	RR Sales, DM Oliveira, BC Silva, JVP Neto, EM Fagundes, RLG Cunha, MT Laloni, CG Ferreira, P Nazareth-Junior
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-10-01
Col·lecció:	Hematology, Transfusion and Cell Therapy
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2531137924025495
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!